HOME >> BIOLOGY >> NEWS
Stanford scientist seeks participants in NASA hypergravity study

If you`ve ever wanted to experience the sensation space shuttle astronauts feel during liftoff and landing - or if spinning around in circles all day inside a large NASA centrifuge is your idea of a good time - then Malcolm Cohen wants to hear from you.

A consulting professor in Stanford`s Department of Human Biology and chief of NASA`s Human Information Processing Branch, Cohen is looking for participants in a groundbreaking study to determine the extent to which people can tolerate prolonged exposure to increased gravitational force - or hypergravity.

``The human body has evolved and adapted to G forces that are relatively constant, except for brief periods of acceleration in planes, cars, merry-go-rounds and so forth,`` Cohen said. ``But there has never been a comprehensive study of the long-term effects of hypergravity on humans.``

To remedy this lack of data, Cohen and his colleagues at the NASA Ames Research Center in Mountain View, Calif., are seeking men between the ages of 18 and 35 who are willing to experience G forces up to two times greater than those normally found on Earth. The study begins in July and will run about nine weeks for each participant. Evaluations of G-tolerance levels in women are expected to be the subject of future experiments.

Those selected for the study will have to endure long hours sitting, and occasionally standing, inside NASA Ames` 20-G centrifuge - a 58-foot-long spinning machine featured in the film Space Cowboys. The centrifuge simulates increasing levels of hypergravity as it rotates faster and faster. For example, to experience the effects of 2 G - twice Earth`s gravitational force - a passenger is spun at nearly 15 revolutions per minute.

Gravity shapes life

A physiological psychologist, Cohen began studying the effects of hypergravity on military jet pilots in the 1960s. He joined the staff of NASA Ames in 1982 - the same year he began teaching a course titled ``
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
19-Mar-2002


Page: 1 2 3 4 5

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
(Date:11/6/2014)... -- A groundbreaking paper from a team of Florida ... of how plants could adapt to and survive environmental ... published in the latest issue of the journal ... (the complex of DNA and proteins) is organized in ... that some genes are turned on and others are ...
(Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
(Date:11/5/2014)... Janeiro, Brazil -Individuals show great diversity in their ability ... and females greatly differ in their perceptual evaluation of ... smell tests. , Sex differences in olfactory ... and may be connected to one,s perception of smell, ... Thus, women,s olfactory superiority has been suggested to be ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2The female nose always knows: Do women have more olfactory neurons? 2
(Date:11/22/2014)... MI (PRWEB) November 22, 2014 ... to simulate the proper management of life-like respiratory ... test lung devices . Grand Rapids-based, Michigan Instruments ... to donate two of the respiratory simulation units ... $15,000 each. Grand Valley and Muskegon Community College ...
(Date:11/21/2014)... 2014 The science of light and ... with more than 200 primary students in a traveling ... University of Otago Physics Department and funded by an ... members of the university’s OSA/SPIE Student Chapter visited six ... giving children from small, rural schools hands-on lessons in ...
(Date:11/21/2014)... The November 2014 issue of BioTechniques ... access journal featuring the following articles:, , ... photoresponsiveness in the retina , DNA from ... using chromogenic substrates in zebrafish , Re-use ... electrophoresis , Nuclear LC3-positive puncta in stressed ...
(Date:11/21/2014)... Nov. 20, 2014 Polaris Group announced ... in its Phase 1 trial of ADI-PEG 20 ... treatment of malignant pleural mesothelioma (MPM) and non-squamous ... clinical trials on ADI-PEG 20, both as monotherapy ... treatment of several other indications, including breast cancer, ...
Breaking Biology Technology:Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
Cached News: